]>
IRCT20151123025202N23 IRCT 2022-05-23 Hamedan University of Medical Sciences The effect of coenzyme Q10 on sudden sensorineural hearing loss treatment Comparison of the effect of coenzyme Q10 and placebo on the hearing status of patients with sudden sensorineural hearing loss 2022-05-22 anticipated 60 Complete https://irct.ir/trial/63486 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: 60 cards will be prepared and write letter I on 30 for intervention and on the other 30 letter C for the control group. Then put them inside the envelope with aluminum wrap and put in a box. At the time of patient arrival, randomly select one of the envelopes and open it, based on selected letter ( I or C) patients will be allocated it to the intervention or control group, Blinding description: This study will be performed double blind, the person who evaluating the outcome of treatment will be unaware of the intervention and control groups. Also participants will be blinded to receiving coenzyme Q10 or placebo according to the same packaging. 3 sudden sensorineural hearing loss. Intervention 1: Intervention group:. Intervention 2: Control group:. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more information
public Abbas Moradi
Hamadan, Shahid Fahmideh Avenue, Medical School, Department of Social Medicine
Hamadan Iran (Islamic Republic of) 6517838736 +98 81 3838 0557 a.moradi@umsha.ac.ir Hamedan University of Medical Sciences scientific Abbas Moradi
Hamadan, Shahid Fahmideh Avenue, Medical School, Department of Social Medicine
Hamadan Iran (Islamic Republic of) 6517838736 +98 81 3838 0557 a.moradi@umsha.ac.ir Hamedan University of Medical Sciences Iran (Islamic Republic of) Unilateral Sudden sensorineural hearing loss Age 18-70 Years Less than one month has passed since the onset of symptoms 18 years 70 years Both History of other ear diseases Presence of a mass or other pathology on ear MRI Conductive hearing loss H90.3 Sensorineural hearing loss, bilateral Treatment - Drugs Treatment - Drugs Intervention group: Control group: Changes in PTA and SRT auditory parameters. Timepoint: 3 and 6 months after starting treatment. Method of measurement: Through audiometry and audiogram parameters. Hearing-related quality of life. Timepoint: 3 and 6 months after starting treatment. Method of measurement: By asking a question: Over the past week, how much has the problem of hearing loss and deafness affected your quality of life in communicating with friends, family and colleagues? And responses on the Likert scale will range from very low to very high. Hamedan University of Medical Sciences Approved 2022-05-08 Ethics committee of Hamadan University of Medical Science ُShahid Fahmideh Ave Hamadan Hamadan Iran (Islamic Republic of)